BDBM683759 6-{6-chloro-4-[(1S,6R)- 3,9- diazabicyclo[4.2.1]nonan- 3-yl]-8-fluoro-2- {[(2S,4R)-4-methoxy-1- methylpyrrolidin-2- yl]methoxy}quinazolin-7- yl}-4-methyl-5- (trifluoromethyl)pyridin- 2-amine::US20240217982, Example 4-4

SMILES CO[C@@H]1C[C@@H](COc2nc(N3CC[C@H]4CC[C@@H](C3)N4)c3cc(Cl)c(c(F)c3n2)-c2nc(N)cc(C)c2C(F)(F)F)N(C)C1

InChI Key InChIKey=BAIFZWLKUNNWOS-UHFFFAOYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 683759   

TargetGTPase KRas [G12D](Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM683759(US20240217982, Example 4-4 | 6-{6-chloro-4-[(1S,6R...)
Affinity DataIC50: 10nMAssay Description:Recombinant GDP-loaded KRAS G12D (20 nM) was treated with compound at room temperature for 20 minutes in assay buffer (10 mM Hepes pH 7.4, 150 mM NaC...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/11/2024
Entry Details
Go to US Patent